Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design

Xin Xin, Ruoyu Miao

Open source

DOI
10.3390/cancers18193126
Published
2026-09-27
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18193126,
  title = {Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design},
  author = {Xin Xin and Ruoyu Miao},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18193126},
  url = {https://doi.org/10.3390/cancers18193126}
}

RIS

TY  - JOUR
TI  - Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design
AU  - Xin Xin
AU  - Ruoyu Miao
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18193126
UR  - https://doi.org/10.3390/cancers18193126
ER  - 

APA

Xin, X., & Miao, R. (2026). Adjuvant and Perioperative Systemic Therapy for Resectable Hepatocellular Carcinoma: Evidence, Biological Rationale, and Trial Design. Cancers. https://doi.org/10.3390/cancers18193126

Source records